Report Detail

Pharma & Healthcare Global Anti-Nausea and Vomiting Healthcare Device Market Research Report 2022

  • RnM4438746
  • |
  • 11 May, 2022
  • |
  • Global
  • |
  • 93 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    1 Anti-Nausea and Vomiting Healthcare Device Market Overview

    • 1.1 Product Overview and Scope of Anti-Nausea and Vomiting Healthcare Device
    • 1.2 Anti-Nausea and Vomiting Healthcare Device Segment by Type
      • 1.2.1 Global Anti-Nausea and Vomiting Healthcare Device Sales Growth Rate Comparison by Type (2022-2028)
      • 1.2.2 Wrist Band
      • 1.2.3 Food
      • 1.2.4 Inhaler
      • 1.2.5 Others
    • 1.3 Anti-Nausea and Vomiting Healthcare Device Segment by Application
      • 1.3.1 Global Anti-Nausea and Vomiting Healthcare Device Sales Comparison by Application: (2022-2028)
      • 1.3.2 For Children
      • 1.3.3 For Pregnant
      • 1.3.4 For other people with motion sickness
    • 1.4 Global Anti-Nausea and Vomiting Healthcare Device Market Size Estimates and Forecasts
      • 1.4.1 Global Anti-Nausea and Vomiting Healthcare Device Revenue 2017-2028
      • 1.4.2 Global Anti-Nausea and Vomiting Healthcare Device Sales 2017-2028
      • 1.4.3 Anti-Nausea and Vomiting Healthcare Device Market Size by Region: 2017 Versus 2021 Versus 2028

    2 Anti-Nausea and Vomiting Healthcare Device Market Competition by Manufacturers

    • 2.1 Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Manufacturers (2017-2022)
    • 2.2 Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Manufacturers (2017-2022)
    • 2.3 Global Anti-Nausea and Vomiting Healthcare Device Average Price by Manufacturers (2017-2022)
    • 2.4 Manufacturers Anti-Nausea and Vomiting Healthcare Device Manufacturing Sites, Area Served, Product Type
    • 2.5 Anti-Nausea and Vomiting Healthcare Device Market Competitive Situation and Trends
      • 2.5.1 Anti-Nausea and Vomiting Healthcare Device Market Concentration Rate
      • 2.5.2 The Global Top 5 and Top 10 Largest Anti-Nausea and Vomiting Healthcare Device Players Market Share by Revenue
      • 2.5.3 Global Anti-Nausea and Vomiting Healthcare Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

    3 Anti-Nausea and Vomiting Healthcare Device Retrospective Market Scenario by Region

    • 3.1 Global Anti-Nausea and Vomiting Healthcare Device Retrospective Market Scenario in Sales by Region: 2017-2022
    • 3.2 Global Anti-Nausea and Vomiting Healthcare Device Retrospective Market Scenario in Revenue by Region: 2017-2022
    • 3.3 North America Anti-Nausea and Vomiting Healthcare Device Market Facts & Figures by Country
      • 3.3.1 North America Anti-Nausea and Vomiting Healthcare Device Sales by Country
      • 3.3.2 North America Anti-Nausea and Vomiting Healthcare Device Revenue by Country
      • 3.3.3 United States
      • 3.3.4 Canada
    • 3.4 Europe Anti-Nausea and Vomiting Healthcare Device Market Facts & Figures by Country
      • 3.4.1 Europe Anti-Nausea and Vomiting Healthcare Device Sales by Country
      • 3.4.2 Europe Anti-Nausea and Vomiting Healthcare Device Revenue by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific Anti-Nausea and Vomiting Healthcare Device Market Facts & Figures by Region
      • 3.5.1 Asia Pacific Anti-Nausea and Vomiting Healthcare Device Sales by Region
      • 3.5.2 Asia Pacific Anti-Nausea and Vomiting Healthcare Device Revenue by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 China Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
    • 3.6 Latin America Anti-Nausea and Vomiting Healthcare Device Market Facts & Figures by Country
      • 3.6.1 Latin America Anti-Nausea and Vomiting Healthcare Device Sales by Country
      • 3.6.2 Latin America Anti-Nausea and Vomiting Healthcare Device Revenue by Country
      • 3.6.3 Mexico
      • 3.6.4 Brazil
      • 3.6.5 Argentina
    • 3.7 Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales by Country
      • 3.7.2 Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Revenue by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 UAE

    4 Global Anti-Nausea and Vomiting Healthcare Device Historic Market Analysis by Type

    • 4.1 Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Type (2017-2022)
    • 4.2 Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Type (2017-2022)
    • 4.3 Global Anti-Nausea and Vomiting Healthcare Device Price by Type (2017-2022)

    5 Global Anti-Nausea and Vomiting Healthcare Device Historic Market Analysis by Application

    • 5.1 Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Application (2017-2022)
    • 5.2 Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Application (2017-2022)
    • 5.3 Global Anti-Nausea and Vomiting Healthcare Device Price by Application (2017-2022)

    6 Key Companies Profiled

    • 6.1 Reliefband
      • 6.1.1 Reliefband Corporation Information
      • 6.1.2 Reliefband Description and Business Overview
      • 6.1.3 Reliefband Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2017-2022)
      • 6.1.4 Reliefband Anti-Nausea and Vomiting Healthcare Device Product Portfolio
      • 6.1.5 Reliefband Recent Developments/Updates
    • 6.2 EmeTerm (WAT Medical)
      • 6.2.1 EmeTerm (WAT Medical) Corporation Information
      • 6.2.2 EmeTerm (WAT Medical) Description and Business Overview
      • 6.2.3 EmeTerm (WAT Medical) Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2017-2022)
      • 6.2.4 EmeTerm (WAT Medical) Anti-Nausea and Vomiting Healthcare Device Product Portfolio
      • 6.2.5 EmeTerm (WAT Medical) Recent Developments/Updates
    • 6.3 Toulifly
      • 6.3.1 Toulifly Corporation Information
      • 6.3.2 Toulifly Description and Business Overview
      • 6.3.3 Toulifly Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2017-2022)
      • 6.3.4 Toulifly Anti-Nausea and Vomiting Healthcare Device Product Portfolio
      • 6.3.5 Toulifly Recent Developments/Updates
    • 6.4 Sea-Bands
      • 6.4.1 Sea-Bands Corporation Information
      • 6.4.2 Sea-Bands Description and Business Overview
      • 6.4.3 Sea-Bands Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2017-2022)
      • 6.4.4 Sea-Bands Anti-Nausea and Vomiting Healthcare Device Product Portfolio
      • 6.4.5 Sea-Bands Recent Developments/Updates
    • 6.5 MotionCure (Sidis Labs)
      • 6.5.1 MotionCure (Sidis Labs) Corporation Information
      • 6.5.2 MotionCure (Sidis Labs) Description and Business Overview
      • 6.5.3 MotionCure (Sidis Labs) Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2017-2022)
      • 6.5.4 MotionCure (Sidis Labs) Anti-Nausea and Vomiting Healthcare Device Product Portfolio
      • 6.5.5 MotionCure (Sidis Labs) Recent Developments/Updates
    • 6.6 Quease EASE (Soothing Scents)
      • 6.6.1 Quease EASE (Soothing Scents) Corporation Information
      • 6.6.2 Quease EASE (Soothing Scents) Description and Business Overview
      • 6.6.3 Quease EASE (Soothing Scents) Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2017-2022)
      • 6.6.4 Quease EASE (Soothing Scents) Anti-Nausea and Vomiting Healthcare Device Product Portfolio
      • 6.6.5 Quease EASE (Soothing Scents) Recent Developments/Updates
    • 6.7 Blisslets
      • 6.6.1 Blisslets Corporation Information
      • 6.6.2 Blisslets Description and Business Overview
      • 6.6.3 Blisslets Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2017-2022)
      • 6.4.4 Blisslets Anti-Nausea and Vomiting Healthcare Device Product Portfolio
      • 6.7.5 Blisslets Recent Developments/Updates
    • 6.8 GRAVOL
      • 6.8.1 GRAVOL Corporation Information
      • 6.8.2 GRAVOL Description and Business Overview
      • 6.8.3 GRAVOL Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2017-2022)
      • 6.8.4 GRAVOL Anti-Nausea and Vomiting Healthcare Device Product Portfolio
      • 6.8.5 GRAVOL Recent Developments/Updates
    • 6.9 Walgreens
      • 6.9.1 Walgreens Corporation Information
      • 6.9.2 Walgreens Description and Business Overview
      • 6.9.3 Walgreens Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2017-2022)
      • 6.9.4 Walgreens Anti-Nausea and Vomiting Healthcare Device Product Portfolio
      • 6.9.5 Walgreens Recent Developments/Updates
    • 6.10 Dramamine(Prestige Consumer Healthcare)
      • 6.10.1 Dramamine(Prestige Consumer Healthcare) Corporation Information
      • 6.10.2 Dramamine(Prestige Consumer Healthcare) Description and Business Overview
      • 6.10.3 Dramamine(Prestige Consumer Healthcare) Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2017-2022)
      • 6.10.4 Dramamine(Prestige Consumer Healthcare) Anti-Nausea and Vomiting Healthcare Device Product Portfolio
      • 6.10.5 Dramamine(Prestige Consumer Healthcare) Recent Developments/Updates
    • 6.11 Psi Bands
      • 6.11.1 Psi Bands Corporation Information
      • 6.11.2 Psi Bands Anti-Nausea and Vomiting Healthcare Device Description and Business Overview
      • 6.11.3 Psi Bands Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2017-2022)
      • 6.11.4 Psi Bands Anti-Nausea and Vomiting Healthcare Device Product Portfolio
      • 6.11.5 Psi Bands Recent Developments/Updates
    • 6.12 NoMo
      • 6.12.1 NoMo Corporation Information
      • 6.12.2 NoMo Anti-Nausea and Vomiting Healthcare Device Description and Business Overview
      • 6.12.3 NoMo Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2017-2022)
      • 6.12.4 NoMo Anti-Nausea and Vomiting Healthcare Device Product Portfolio
      • 6.12.5 NoMo Recent Developments/Updates

    7 Anti-Nausea and Vomiting Healthcare Device Manufacturing Cost Analysis

    • 7.1 Anti-Nausea and Vomiting Healthcare Device Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of Anti-Nausea and Vomiting Healthcare Device
    • 7.4 Anti-Nausea and Vomiting Healthcare Device Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Anti-Nausea and Vomiting Healthcare Device Distributors List
    • 8.3 Anti-Nausea and Vomiting Healthcare Device Customers

    9 Anti-Nausea and Vomiting Healthcare Device Market Dynamics

    • 9.1 Anti-Nausea and Vomiting Healthcare Device Industry Trends
    • 9.2 Anti-Nausea and Vomiting Healthcare Device Market Drivers
    • 9.3 Anti-Nausea and Vomiting Healthcare Device Market Challenges
    • 9.4 Anti-Nausea and Vomiting Healthcare Device Market Restraints

    10 Global Market Forecast

    • 10.1 Anti-Nausea and Vomiting Healthcare Device Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of Anti-Nausea and Vomiting Healthcare Device by Type (2023-2028)
      • 10.1.2 Global Forecasted Revenue of Anti-Nausea and Vomiting Healthcare Device by Type (2023-2028)
    • 10.2 Anti-Nausea and Vomiting Healthcare Device Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of Anti-Nausea and Vomiting Healthcare Device by Application (2023-2028)
      • 10.2.2 Global Forecasted Revenue of Anti-Nausea and Vomiting Healthcare Device by Application (2023-2028)
    • 10.3 Anti-Nausea and Vomiting Healthcare Device Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of Anti-Nausea and Vomiting Healthcare Device by Region (2023-2028)
      • 10.3.2 Global Forecasted Revenue of Anti-Nausea and Vomiting Healthcare Device by Region (2023-2028)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      Summary:

      Industry Insights
      Due to the COVID-19 pandemic, the global Anti-Nausea and Vomiting Healthcare Device market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Anti-Nausea and Vomiting Healthcare Device market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Anti-Nausea and Vomiting Healthcare Device landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
      Wrist Band accounting for % of the Anti-Nausea and Vomiting Healthcare Device global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While For Children segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
      The global major manufacturers of Anti-Nausea and Vomiting Healthcare Device include Reliefband, EmeTerm (WAT Medical), Toulifly, Sea-Bands, MotionCure (Sidis Labs), Quease EASE (Soothing Scents), Blisslets, GRAVOL and Walgreens, etc. In terms of revenue, the global 3 largest players have a % market share of Anti-Nausea and Vomiting Healthcare Device in 2021.
      This report focuses on Anti-Nausea and Vomiting Healthcare Device volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Anti-Nausea and Vomiting Healthcare Device market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
      Key Drivers & Barriers
      High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
      Post-covid-19 Outlook
      The readers in the section will understand how the Anti-Nausea and Vomiting Healthcare Device market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
      Segmental Outlook
      Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).
      Segment by Type
      Wrist Band
      Food
      Inhaler
      Others
      Segment by Application
      For Children
      For Pregnant
      For other people with motion sickness
      Regional Outlook
      This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Scenario
      In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
      Reliefband
      EmeTerm (WAT Medical)
      Toulifly
      Sea-Bands
      MotionCure (Sidis Labs)
      Quease EASE (Soothing Scents)
      Blisslets
      GRAVOL
      Walgreens
      Dramamine(Prestige Consumer Healthcare)
      Psi Bands
      NoMo
      Frequently Asked Questions
      Which product segment grabbed the largest share in the Anti-Nausea and Vomiting Healthcare Device market?
      How is the competitive scenario of the Anti-Nausea and Vomiting Healthcare Device market?
      Which are the key factors aiding the Anti-Nausea and Vomiting Healthcare Device market growth?
      Which are the prominent players in the Anti-Nausea and Vomiting Healthcare Device market?
      Which region holds the maximum share in the Anti-Nausea and Vomiting Healthcare Device market?
      What will be the CAGR of the Anti-Nausea and Vomiting Healthcare Device market during the forecast period?
      Which application segment emerged as the leading segment in the Anti-Nausea and Vomiting Healthcare Device market?
      What key trends are likely to emerge in the Anti-Nausea and Vomiting Healthcare Device market in the coming years?
      What will be the Anti-Nausea and Vomiting Healthcare Device market size by 2028?
      Which company held the largest share in the Anti-Nausea and Vomiting Healthcare Device market?


      Summary:
      Get latest Market Research Reports on Anti-Nausea and Vomiting Healthcare Device. Industry analysis & Market Report on Anti-Nausea and Vomiting Healthcare Device is a syndicated market report, published as Global Anti-Nausea and Vomiting Healthcare Device Market Research Report 2022. It is complete Research Study and Industry Analysis of Anti-Nausea and Vomiting Healthcare Device market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,900.00
      $5,800.00
      2,325.80
      4,651.60
      2,746.30
      5,492.60
      371,635.00
      743,270.00
      225,765.00
      451,530.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report